Sean Bennett1, Laura K Baker2, Guillaume Martel1, Risa Shorr3, Timothy M Pawlik4, Alan Tinmouth5, Daniel I McIsaac6, Paul C Hébert7, Paul J Karanicolas8, Lauralyn McIntyre5, Alexis F Turgeon9, Jeffrey Barkun10, Dean Fergusson1. 1. Department of Surgery, University of Ottawa, Ottawa, ON, Canada; The Ottawa Hospital, Ottawa, ON, Canada; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada. 2. Department of Surgery, University of Ottawa, Ottawa, ON, Canada; The Ottawa Hospital, Ottawa, ON, Canada. 3. The Ottawa Hospital, Ottawa, ON, Canada. 4. Department of Surgery, The Ohio State University, Columbus, OH, USA. 5. The Ottawa Hospital, Ottawa, ON, Canada; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada; Department of Medicine, University of Ottawa, Ottawa, ON, Canada. 6. The Ottawa Hospital, Ottawa, ON, Canada; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada; Department of Anesthesiology, University of Ottawa, Ottawa, ON, Canada. 7. Department of Medicine, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada. 8. Department of Surgery, University of Toronto, Toronto, ON, Canada. 9. Department of Anesthesiology, Université Laval, Québec, QC, Canada. 10. Department of Surgery, McGill University, Montréal, QC, Canada.
Abstract
BACKGROUND: Liver resection is associated with a high proportion of red blood cell transfusions. There is a proposed association between perioperative transfusions and increased risk of complications and tumor recurrence. This study reviews the evidence of this association in the literature. METHODS: The Medline, EMBASE, and Cochrane databases were searched for clinical trials or observational studies of patients undergoing liver resection that compared patients who did and did not receive a perioperative red blood cell transfusion. Outcomes were mortality, complications, and cancer survival. RESULTS: Twenty-two studies involving 6832 patients were included. All studies were retrospective, with no clinical trials. No studies were scored as low risk of bias. The overall proportion of patients transfused was 38.3%. After multivariate analysis, 1 of 5 studies demonstrated an association between transfusion and increased mortality; 5 of 6 demonstrated an association between transfusion and increased complications; and 10 of 18 demonstrated an association between transfusion and decreased cancer survival. CONCLUSION: This review supports the evidence linking perioperative blood transfusions to negative outcomes. The most convincing association was with post-operative complications, some association with long-term cancer outcomes, and no convincing association with mortality. These findings support the initiation, and further study, of restrictive transfusion protocols.
BACKGROUND: Liver resection is associated with a high proportion of red blood cell transfusions. There is a proposed association between perioperative transfusions and increased risk of complications and tumor recurrence. This study reviews the evidence of this association in the literature. METHODS: The Medline, EMBASE, and Cochrane databases were searched for clinical trials or observational studies of patients undergoing liver resection that compared patients who did and did not receive a perioperative red blood cell transfusion. Outcomes were mortality, complications, and cancer survival. RESULTS: Twenty-two studies involving 6832 patients were included. All studies were retrospective, with no clinical trials. No studies were scored as low risk of bias. The overall proportion of patients transfused was 38.3%. After multivariate analysis, 1 of 5 studies demonstrated an association between transfusion and increased mortality; 5 of 6 demonstrated an association between transfusion and increased complications; and 10 of 18 demonstrated an association between transfusion and decreased cancer survival. CONCLUSION: This review supports the evidence linking perioperative blood transfusions to negative outcomes. The most convincing association was with post-operative complications, some association with long-term cancer outcomes, and no convincing association with mortality. These findings support the initiation, and further study, of restrictive transfusion protocols.
Authors: Demetrios Moris; Amir A Rahnemai-Azar; Diamantis I Tsilimigras; Ioannis Ntanasis-Stathopoulos; Hugo P Marques; Eleftherios Spartalis; Evangelos Felekouras; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2017-11-03 Impact factor: 3.452
Authors: Richard W D Gilbert; Tori Lenet; Sean P Cleary; Rory Smoot; Ching-Wei D Tzeng; Flavio G Rocha; Guillaume Martel; Kimberly A Bertens Journal: Ann Surg Oncol Date: 2022-06-15 Impact factor: 4.339
Authors: S Bennett; K Søreide; S Gholami; P Pessaux; C Teh; E Segelov; H Kennecke; H Prenen; S Myrehaug; D Callegaro; J Hallet Journal: Curr Oncol Date: 2020-10-01 Impact factor: 3.677
Authors: Laura Baker; Lily Park; Richard Gilbert; Andre Martel; Hilalion Ahn; Alexandra Davies; Daniel I McIsaac; Elianna Saidenberg; Alan Tinmouth; Dean A Fergusson; Guillaume Martel Journal: BMJ Open Date: 2019-06-17 Impact factor: 2.692
Authors: Melissa L Bellomy; Milo C Engoren; Barbara J Martin; Yaping Shi; Matthew S Shotwell; Christopher G Hughes; Robert E Freundlich Journal: Anesth Analg Date: 2021-01 Impact factor: 6.627